These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 280159)

  • 1. Relationship of structure and antiviral activity of 9-beta-D-arabinofuranosyladenine analogs.
    Haskell TH
    Ann N Y Acad Sci; 1977 Mar; 284():81-90. PubMed ID: 280159
    [No Abstract]   [Full Text] [Related]  

  • 2. Prodrugs of 9-beta-D-arabinofuranosyladenine. 1. Synthesis and evaluation of some 5'-(O-acyl) derivatives.
    Baker DC; Haskell TH; Putt SR
    J Med Chem; 1978 Dec; 21(12):1218-21. PubMed ID: 722731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and antiviral activity of certain 5'-monophosphates of 9-D-arabinofuranosyladenine and 9-D-arabinofuranosylhypoxanthine.
    Revankar GR; Huffman JH; Allen LB; Sidwell RW; Robins RK; Tolman RL
    J Med Chem; 1975 Jul; 18(7):721-6. PubMed ID: 1171242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2-Substituted derivatives of 9-alpha-D-arabinofuranosyladenine and 9-alpha-D-arabinofuranosyl-8-azaadenine.
    Montgomery JA; Shortnacy AT; Arnett G; Shannon WM
    J Med Chem; 1977 Mar; 20(3):401-4. PubMed ID: 191611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2',3'-Dideoxy-2'-fluoro-ara-A. An acid-stable purine nucleoside active against human immunodeficiency virus (HIV).
    Marquez VE; Tseng CK; Kelley JA; Mitsuya H; Broder S; Roth JS; Driscoll JS
    Biochem Pharmacol; 1987 Sep; 36(17):2719-22. PubMed ID: 3651175
    [No Abstract]   [Full Text] [Related]  

  • 6. Prodrugs of 9-(beta-D-arabinofuranosyl)adenine 2. Synthesis and evaluation of a number of 2',3'- and 3',5'-di-O-acyl derivatives.
    Baker DC; Haskell TH; Putt SR; Sloan BJ
    J Med Chem; 1979 Mar; 22(3):273-9. PubMed ID: 218013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of N6- or 8-substituted 9-(beta-D-arabinofuranosyl)-adenines and their antiviral activities against herpes simplex and vaccinia viruses.
    Kaneko M; Kimura M; Nishimura T; Shimizu B
    Chem Pharm Bull (Tokyo); 1977 Oct; 25(10):2482-9. PubMed ID: 201386
    [No Abstract]   [Full Text] [Related]  

  • 8. 1-beta-D-arabinofuranosyl-1H-imidazo[4,5-c]pyridine (ara-3-deazaadenine).
    Montgomery JA; Clayton SJ; Chiang PK
    J Med Chem; 1982 Jan; 25(1):96-8. PubMed ID: 6283083
    [No Abstract]   [Full Text] [Related]  

  • 9. Anti-herpes activity of the adenine arabinoside analog, 2'-azido-2'-deoxy-beta-D-arabinofuranosyladenine.
    Cermak-Mörth CM; Christian R; Unger FM
    Biochem Pharmacol; 1979 Jul; 28(13):2105-8. PubMed ID: 224885
    [No Abstract]   [Full Text] [Related]  

  • 10. The antiviral activity of 9-beta-D-arabinofuranosyladenine is enhanced by the 2',3'-dideoxyriboside, the 2',3'-didehydro-2',3'-dideoxyriboside and the 3'-azido-2',3'-dideoxyriboside of 2,6-diaminopurine.
    Balzarini J; De Clercq E
    Biochem Biophys Res Commun; 1989 Feb; 159(1):61-7. PubMed ID: 2538128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological activities and modes of action of 9-alpha-D-arabinofuranosyladenine and 9-alpha-D-arabinofuranosyl-8-azaadenine.
    Bennett LL; Allan PW; Shaddix SC; Shannon WM; Arnett G; Westbrook L; Drach JC; Reinke CM
    Biochem Pharmacol; 1981 Aug; 30(16):2325-32. PubMed ID: 6271140
    [No Abstract]   [Full Text] [Related]  

  • 12. Synthesis and biologic activity of 2'-fluoro-2-halo derivatives of 9-beta-D-arabinofuranosyladenine.
    Montgomery JA; Shortnacy-Fowler AT; Clayton SD; Riordan JM; Secrist JA
    J Med Chem; 1992 Jan; 35(2):397-401. PubMed ID: 1732556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytotoxic activity of the adenine arabinoside analogs, 2'-azido- and 2'-amino-2'-deoxy-beta-D-arabinofuranosyladenine.
    Lee SH; Unger FM; Christian R; Sartorelli AC
    Biochem Pharmacol; 1979 Apr; 28(7):1267-9. PubMed ID: 444286
    [No Abstract]   [Full Text] [Related]  

  • 14. Interaction of 9-beta-D-arabinofuranosyladenine, 9-beta-D-arabinofuranosyladenine 5'-monophosphate, and 9-beta-D-arabinofuranosyladenine 5'-triphosphate with S-adenosylhomocysteinase.
    Helland S; Ueland PM
    Cancer Res; 1981 Feb; 41(2):673-8. PubMed ID: 6160909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An evaluation of certain chain-extended analogues of 9-beta-D-arabinofuranosyladenine for antiviral and cardiovascular activity.
    Baker DC; Crews RP; Haskell TH; Putt SR; Arnett G; Shannon WM; Reinke CM; Katlama NB; Drach JC
    J Med Chem; 1983 Oct; 26(10):1530-4. PubMed ID: 6312045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A highly efficient synthesis of cyclaradine and its behaviour towards adenosine deaminase.
    Katagiri N; Kokufuda H; Makino M; Matsuhashi Y; Kaneko C; Vince R
    Nucleic Acids Symp Ser; 1997; (37):3-4. PubMed ID: 9585970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of activity of herpes virus inhibitors.
    Collins P; Bauer DJ
    J Antimicrob Chemother; 1977 Mar; 3 Suppl A():73-81. PubMed ID: 405365
    [No Abstract]   [Full Text] [Related]  

  • 18. Differential sensitivity of herpes simplex virus types 1 and 2 to human interferon: antiviral effects of interferon plus 9-beta-D-arabinofuranosyladenine.
    Lerner AM; Bailey EJ
    J Infect Dis; 1976 Oct; 134(4):400-4. PubMed ID: 185303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the toxicity and metabolism of 9-beta-D-arabinofuranosyl-2-fluoroadenine and 9-beta-D-arabinofuranosyladenine in human lymphoblastoid cells.
    Plunkett W; Chubb S; Alexander L; Montgomery JA
    Cancer Res; 1980 Jul; 40(7):2349-55. PubMed ID: 6966966
    [No Abstract]   [Full Text] [Related]  

  • 20. Sequence-specific inhibition of DNA strand elongation by incorporation of 9-beta-D-arabinofuranosyladenine.
    Ohno Y; Spriggs D; Matsukage A; Ohno T; Kufe D
    Cancer Res; 1989 Apr; 49(8):2077-81. PubMed ID: 2467740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.